Prof Danny Rischin
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
523 Scholarly works
8 Projects
HIGHLIGHTS
2026
Journal article
Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study
DOI: 10.1016/j.jaad.2025.11.0802026
Journal article
INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
DOI: 10.1158/1078-0432.CCR-25-11972026
Journal article
Prospective Evaluation of Patient Priorities in Human Papillomavirus-Driven Oropharyngeal Cancer Using the Chicago Priorities Scale: Considerations for Future Clinical Trial Design
DOI: 10.1016/j.ijrobp.2025.08.0532026
Research grants (ARC, NHMRC, MRFF)
Expanding the Role of Immunotherapy in Cutaneous and Mucosal Head and Neck Squamous Cell Carcinomas
2025
Research grants (ARC, NHMRC, MRFF)
Novel Treatment of Radiation Associated Dysphagia With Statins (TRADstat)
2024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12020
Research grants (ARC, NHMRC, MRFF)
Defining the Role of Immunotherapy and Immune Biomarkers in Head and Neck and Cutaneous Squamous Cell Carcinomas
RECENT SCHOLARLY WORKS
2026
Journal article
Examining CD103 Tissue-Resident Memory T Cells in Nasopharyngeal Carcinoma
DOI: 10.1002/hed.700262026
Journal article
Adjuvant nivolumab for resected high-risk head and neck cancer
DOI: 10.1016/S0140-6736(26)00133-92026
Journal article
Radiation Therapy Target Objectives for Tonsillar Cancer Treated With Unilateral Radiation Therapy—a Replanning Study From TROG 12.01
DOI: 10.1016/j.ijrobp.2025.12.0582025
Journal article
Swallowing and Communication Outcomes Post Chemoradiotherapy for Low-Risk Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma: A Substudy of TROG 12.01
DOI: 10.1002/hed.282452025
Journal article
Evaluating CD103 intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal Cancer
DOI: 10.1016/j.oraloncology.2025.1077922025
Journal article
The authors reply
DOI: 10.1056/NEJMc25133092025
Journal article
EXPLORING TRANSCRIPTIONAL SUBTYPES AND IMMUNE MARKERS IN BEACON; PHASE II STUDY OF ATEZOLIZUMAB, BEVACIZUMAB, COBIMETINIB IN PLATINUM RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
DOI: 10.1016/j.ijgc.2025.102500
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
Expanding the Role of Immunotherapy in Cutaneous and Mucosal Head and Neck Squamous Cell Carcinomas